V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214388 | 20080691 | 1.7 | 50.4 | Palliative (P) | 2018-10-24 | 2018-10-31 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100756555 |
| 20214389 | 20080692 | null | 61.6 | Palliative (P) | 2019-10-30 | 2019-11-05 | Cape+Cisplatin+Trastuzumab Load | 02 | N | IMATINIB | 101274360 |
| 20214391 | 20080693 | null | null | 03 | 2019-06-11 | 2019-06-12 | LANREOTIDE | 02 | N | LANREOTIDE | 101629720 |
| 20214392 | 20080694 | 1.67 | 56.6 | Palliative (P) | 2017-11-17 | 2017-11-30 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100407029 |
| 20214394 | 20080696 | 1.59 | 73.6 | Palliative (P) | 2016-03-26 | 2016-03-30 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100897357 |
| 20214395 | 20080697 | 1.7 | 66.5 | Curative (C) | 2018-04-28 | 2018-05-19 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100069783 |
| 20214396 | 20080698 | null | null | Curative (C) | 2016-04-23 | 2016-05-17 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101219015 |
| 20214397 | 20080699 | 1.75 | 72.7 | Palliative (P) | 2018-04-15 | 2018-04-22 | HCX (Cape + Cisp + Tras) - Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100140643 |
| 20214398 | 20080700 | 1.95 | 80 | Palliative (P) | 2021-03-31 | 2021-04-10 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101509617 |
| 20214399 | 20080701 | 1.66 | 0 | Palliative (P) | 2016-08-25 | 2016-09-14 | Cape+Cisplatin+Trastuzumab Load | 02 | N | TRIAL | 101069587 |
| 20214400 | 20080702 | 1.77 | 0 | Palliative (P) | 2017-02-26 | 2017-03-05 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101129514 |
| 20214401 | 20080703 | 1.57 | 75.7 | Palliative (P) | 2019-06-22 | 2019-06-30 | HCX (Cape + Cisp + Tras) - Load | 02 | N | TRIAL | 101188921 |
| 20214403 | 20080704 | 1.59 | 71.9 | Curative (C) | 2019-09-16 | 2019-10-10 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 100968716 |
| 20214404 | 20080705 | 1.63 | 64 | Palliative (P) | 2018-06-18 | 2018-07-03 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101657638 |
| 20214405 | 20080706 | 1.73 | 88 | Neo-adjuvant (N) | 2017-03-04 | 2017-04-04 | HCX (Cape + Cisp + Tras) - Main | 02 | N | TRIAL | 100813027 |
| 20214406 | 20080707 | 1.7 | 59 | Curative (C) | null | 2016-12-10 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | FLUOROURACIL + MITOMYCIN + RT | 101166960 |
| 20214407 | 20080708 | 0 | 76 | Palliative (P) | 2020-01-25 | 2020-02-02 | LANREOTIDE | 02 | N | LANREOTIDE | 101343130 |
| 20214409 | 20080709 | null | null | Palliative (P) | 2018-11-28 | 2018-12-14 | Trial Unspecified | 1 | N | TRIAL | 100358330 |
| 20214411 | 20080711 | 1.85 | 59.9 | 03 | 2017-05-28 | 2017-05-28 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100425643 |
| 20214414 | 20080712 | 1.85 | 83.9 | Adjuvant (A) | 2019-03-12 | 2019-03-12 | Imatinib 400mg | 02 | N | IMATINIB | 101813971 |
| 20214416 | 20080713 | 1.64 | 0 | null | null | 2017-11-26 | Fluorouracil+Mitomycin+RT (Bladder) | 02 | null | FLUOROURACIL + MITOMYCIN + RT | 100137742 |
| 20214417 | 20080714 | 1.63 | 102.2 | Adjuvant (A) | 2016-10-30 | 2016-10-31 | Trial Unspecified | Y | N | TRIAL | 101853115 |
| 20214418 | 20080715 | 1.67 | null | Palliative (P) | 2016-03-12 | 2016-03-14 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | TRIAL | 100467468 |
| 20214420 | 20080716 | 1.73 | 78.5 | Curative (C) | 2018-02-14 | 2018-02-26 | FLUOROURACIL + MITOMYCIN + RT | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100626429 |
| 20214421 | 20080717 | 1.67 | 61.8 | Curative (C) | 2019-04-09 | 2019-04-18 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101287588 |
| 20214422 | 20080718 | 1.7 | 66 | Palliative (P) | 2018-04-12 | 2018-04-12 | Trial Unspecified | Y | N | TRIAL | 100625155 |
| 20214423 | 20080719 | 1.77 | 0 | Palliative (P) | 2019-02-12 | 2019-03-03 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100141526 |
| 20214424 | 20080720 | 1.55 | 60.5 | Palliative (P) | 2016-07-24 | 2016-07-24 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101717630 |
| 20214425 | 20080721 | 1.54 | 87 | Palliative (P) | 2016-08-23 | 2016-09-09 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100366098 |
| 20214426 | 20080722 | 1.66 | 0 | null | 2017-10-20 | 2017-10-24 | HCX | 02 | null | LANREOTIDE | 100070454 |
| 20214429 | 20080723 | null | null | Neo-adjuvant (N) | 2019-08-13 | 2019-08-25 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | IMATINIB | 101298321 |
| 20214430 | 20080724 | 1.59 | 73.6 | Curative (C) | null | 2019-03-28 | FLUOROURACIL + MITOMYCIN + RT | N | N | FLUOROURACIL + MITOMYCIN + RT | 100601054 |
| 20214433 | 20080727 | 1.56 | 44 | Palliative (P) | 2018-04-25 | 2018-04-29 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100597073 |
| 20214434 | 20080728 | 1.74 | 88.8 | null | 2019-07-09 | 2019-08-21 | LANREOTIDE | 99 | N | LANREOTIDE | 101867404 |
| 20214435 | 20080729 | 1.66 | 83.3 | Curative (C) | 2019-04-24 | 2019-05-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101045950 |
| 20214436 | 20080730 | 1.75 | 92.4 | Palliative (P) | 2017-11-28 | 2017-12-15 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100876801 |
| 20214437 | 20080731 | 0 | 56.5 | 03 | 2018-06-28 | 2018-06-28 | LANREOTIDE | 02 | N | LANREOTIDE | 100482006 |
| 20214439 | 20080733 | 1.6 | 82.8 | Curative (C) | 2020-03-09 | 2020-03-21 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100433844 |
| 20214440 | 20080734 | null | null | Curative (C) | 2016-10-11 | 2016-10-31 | FLUOROURACIL + MITOMYCIN + RT | N | N | FLUOROURACIL + MITOMYCIN + RT | 100665461 |
| 20214442 | 20080736 | 1.65 | 46 | Curative (C) | 2017-06-30 | 2017-07-11 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100736970 |
| 20214444 | 20080738 | 1.87 | 64.1 | Palliative (P) | 2018-07-06 | 2018-07-18 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101198319 |
| 20214445 | 20080739 | null | null | Palliative (P) | 2018-03-23 | 2018-03-30 | LANREOTIDE | 02 | N | LANREOTIDE | 100120271 |
| 20214446 | 20080740 | 1.75 | 66.8 | Curative (C) | 2019-05-22 | 2019-05-31 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | Y | FLUOROURACIL + MITOMYCIN + RT | 100745124 |
| 20214448 | 20080741 | 1.6 | 67 | Curative (C) | 2017-12-23 | 2018-01-02 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101827056 |
| 20214452 | 20080743 | 1.68 | 62.55 | Palliative (P) | 2016-12-05 | 2016-12-11 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101793752 |
| 20214453 | 20080744 | 1.83 | null | Palliative (P) | 2018-02-03 | 2018-02-03 | IMATINIB | 02 | N | IMATINIB | 100248200 |
| 20214457 | 20080746 | 1.85 | 75.4 | Palliative (P) | 2020-04-10 | 2020-04-21 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101675830 |
| 20214458 | 20080747 | 1.52 | 0 | Curative (C) | 2018-07-18 | 2018-08-06 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 100411350 |
| 20214459 | 20080748 | 1.72 | 0 | Curative (C) | 2019-09-30 | 2019-10-28 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | FLUOROURACIL + MITOMYCIN + RT | 101165834 |
| 20214461 | 20080749 | 1.59 | 73.6 | Palliative (P) | null | 2013-05-24 | null | null | N | TRIAL | 101848460 |